Home068270 • KRX
add
Celltrion Inc
Previous close
₩172,000.00
Day range
₩170,400.00 - ₩172,500.00
Year range
₩144,615.31 - ₩193,223.36
Market cap
39.65T KRW
Avg Volume
316.74K
P/E ratio
69.57
Dividend yield
0.40%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 961.46B | 9.91% |
Operating expense | 301.28B | 2.01% |
Net income | 61.17B | -21.59% |
Net profit margin | 6.36 | -28.70% |
Earnings per share | 276.00 | -20.06% |
EBITDA | 319.79B | 56.22% |
Effective tax rate | -20.74% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 824.00B | -20.06% |
Total assets | 20.55T | 2.10% |
Total liabilities | 3.89T | 24.20% |
Total equity | 16.66T | — |
Shares outstanding | 220.28M | — |
Price to book | 2.29 | — |
Return on assets | 2.93% | — |
Return on capital | 3.14% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 61.17B | -21.59% |
Cash from operations | 188.14B | -35.92% |
Cash from investing | -115.46B | -211.15% |
Cash from financing | -196.36B | 20.36% |
Net change in cash | -178.62B | -213.72% |
Free cash flow | 92.77B | -9.21% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Founded
2002
Website
Employees
2,680
